In Utero Haematopoietic Stem Cell Transplantation
Author Information
Author(s): Renda Maria Concetta Maggio, Aurelio Maggio
Primary Institution: Ospedali Riuniti 'Villa Sofia-Cervello', Palermo
Hypothesis
Can in utero haematopoietic stem cell transplantation (IUHSCT) effectively treat genetic disorders in fetuses?
Conclusion
The study suggests that while IUHSCT shows promise, achieving therapeutic levels of donor cell chimerism remains a significant challenge.
Supporting Evidence
- Successful engraftment was only achieved in cases of X-SCID among the reported IUHSCT cases.
- Animal models showed low levels of engraftment that were not therapeutic.
- Strategies to improve donor cell competition and define immunological windows are necessary for better outcomes.
Takeaway
Doctors are trying to give sick babies healthy blood cells before they are born, but it's really hard to make it work.
Methodology
The study reviews cases of IUHSCT in humans and animal models, discussing barriers to engraftment and potential strategies to improve outcomes.
Limitations
The study highlights the limited success in achieving useful levels of chimerism in non-immunodeficiency diseases and the unclear reasons for failures.
Participant Demographics
The study includes 46 reported cases of IUHSCT in humans, primarily focusing on genetic disorders.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website